950140 — Englewood Lab Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeSmall CapNeutral

Annual balance sheet for Englewood Lab, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	9.46	7.51	8.78	13.9	26.4
Net Total Accounts Receivable
Net Total Receivables	20.8	30	28.7	54.9	44.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	63.2	74	74.9	102	99.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	35.7	31.6	30.3	28.5	30.1
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	99.9	108	107	135	136
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	28.5	23.5	27.7	39.8	30
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	44.2	39.8	33.4	45.5	38
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	55.8	68.3	73.4	89.1	97.9
Total Liabilities & Shareholders' Equity	99.9	108	107	135	136
Total Common Shares Outstanding